India's Aarti Drugs climbs on Q4 profit growth

Aarti Drugs

02/05/2023 08:55

** Shares of Aarti Drugs  ADRG.NS  rise as much as 8.8%
after co reported a 1.4% rise in Q4 net profit
    ** Revenue from APIs and specialty chemicals grew 10% and
56%; revenue from ops up 6.9%
    ** Stock crosses its 200-day exponential moving average;
continues to stay above 50- and 100-day avgs
    ** Stock's MACD line above the signal line since April 5,
indicating bullish momentum
    ** Stock posts its sharpest intraday pct gain since April 6
    ** More than ~1.1 mln shares change hands by 1:06 p.m. IST,
0.7x the 30-day avg
    ** Including session's gains, stock cuts YTD loss to 1.35%
from 8.5% at last close

 (Reporting by Dimpal Gulwani in Bengaluru)
 ((dimpal.gulwani@thomsonreuters.com))